{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T01:52:11Z","timestamp":1791337931848,"version":"4.3.1"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure: European Journal of Epilepsy"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.seizure.2022.07.003","type":"journal-article","created":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T12:38:17Z","timestamp":1657283897000},"page":"109-114","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Efficacy and safety of antiseizure medication in post-stroke epilepsy"],"prefix":"10.1016","volume":"100","author":[{"given":"Yaroslav","family":"Winter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timo","family":"Uphaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3907-5192","authenticated-orcid":false,"given":"Katharina","family":"Sandner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2149-5810","authenticated-orcid":false,"given":"Sven","family":"Klimpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian von","family":"Stuckrad-Barre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergiu","family":"Groppa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.seizure.2022.07.003_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.105129","article-title":"Quality of life and resilience of patients with juvenile stroke: a systematic review","volume":"29","author":"Bartholome","year":"2020","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.seizure.2022.07.003_bib0002","doi-asserted-by":"crossref","first-page":"l6983","DOI":"10.1136\/bmj.l6983","article-title":"Management of acute ischemic stroke","volume":"368","author":"Phipps","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.seizure.2022.07.003_bib0003","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1179\/1074935715Z.00000000062","article-title":"The pooled incidence of post-stroke seizure in 102 008 patients","volume":"22","author":"Zou","year":"2015","journal-title":"Top Stroke Rehabil"},{"key":"10.1016\/j.seizure.2022.07.003_bib0004","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/ane.12218","article-title":"Epilepsy in the elderly: comparing clinical characteristics with younger patients","volume":"129","author":"Stefan","year":"2014","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.seizure.2022.07.003_bib0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0136200","article-title":"Seizure outcomes and predictors of recurrent post-stroke seizure: a retrospective observational cohort study","volume":"10","author":"Tanaka","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.seizure.2022.07.003_bib0006","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci11040418","article-title":"Predictors of pharmaco-resistance in patients with post-stroke epilepsy","volume":"11","author":"Lattanzi","year":"2021","journal-title":"Brain Sci"},{"key":"10.1016\/j.seizure.2022.07.003_bib0007","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.yebeh.2017.12.037","article-title":"Health-related quality of life in patients with poststroke epilepsy","volume":"80","author":"Winter","year":"2018","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2022.07.003_bib0008","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/WCO.0000000000000067","article-title":"Antiepileptogenesis in humans: disappointing clinical evidence and ways to move forward","volume":"27","author":"Trinka","year":"2014","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.seizure.2022.07.003_bib0009","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007144.pub2","article-title":"Immediate antiepileptic drug treatment, versus placebo, deferred, or no treatment for first unprovoked seizure","author":"Leone","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.seizure.2022.07.003_bib0010","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.seizure.2018.08.001","article-title":"Randomized controlled trials of antiepileptic drugs for the treatment of post-stroke seizures: a systematic review with network meta-analysis","volume":"61","author":"Brigo","year":"2018","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2022.07.003_bib0011","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/epi.12550","article-title":"ILAE official report: a practical clinical definition of epilepsy","volume":"55","author":"Fisher","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2022.07.003_bib0012","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s40263-016-0406-8","article-title":"Tolerability and safety of commonly used antiepileptic drugs in adolescents and adults: a clinician's overview","volume":"31","author":"Brodie","year":"2017","journal-title":"CNS Drugs"},{"key":"10.1016\/j.seizure.2022.07.003_bib0013","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/s40263-017-0480-6","article-title":"Comparing safety and efficacy of \"third-generation\" antiepileptic drugs: long-term extension and post-marketing treatment","volume":"31","author":"Kwok","year":"2017","journal-title":"CNS Drugs"},{"key":"10.1016\/j.seizure.2022.07.003_bib0014","doi-asserted-by":"crossref","first-page":"e405","DOI":"10.1002\/hsr2.405","article-title":"Antiepileptic medicines in men and women with stroke in Sweden, a registry-based study","volume":"4","author":"Karlsson Lind","year":"2021","journal-title":"Health Sci Rep"},{"key":"10.1016\/j.seizure.2022.07.003_bib0015","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/epi.17137","article-title":"Relative importance of clinical outcomes and safety risks of antiseizure medication monotherapy for patients and physicians: discrete choice experiment eliciting preferences in real-world study \"VOTE\"","volume":"63","author":"Rosenow","year":"2022","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2022.07.003_bib0016","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1159\/000342669","article-title":"Levetiracetam versus carbamazepine in patients with late poststroke seizures: a multicenter prospective randomized open-label study (EpIC Project)","volume":"34","author":"Consoli","year":"2012","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.seizure.2022.07.003_bib0017","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/WNF.0b013e3180333069","article-title":"Monotherapy of lamotrigine versus carbamazepine in patients with poststroke seizure","volume":"30","author":"Gilad","year":"2007","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.seizure.2022.07.003_bib0018","article-title":"Association between antiseizure drug monotherapy and mortality for patients with poststroke epilepsy","author":"Larsson","year":"2021","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.seizure.2022.07.003_bib0019","doi-asserted-by":"crossref","first-page":"e2330","DOI":"10.1002\/brb3.2330","article-title":"Antiseizure medications for post-stroke epilepsy: a real-world prospective cohort study","volume":"11","author":"Tanaka","year":"2021","journal-title":"Brain Behav"},{"key":"10.1016\/j.seizure.2022.07.003_bib0020","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/ane.13323","article-title":"Eslicarbazepine acetate in post-stroke epilepsy: clinical practice evidence from Euro-Esli","volume":"142","author":"Sales","year":"2020","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.seizure.2022.07.003_bib0021","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/ane.13230","article-title":"Lacosamide in patients with epilepsy of cerebrovascular etiology","volume":"141","author":"Rosenow","year":"2020","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.seizure.2022.07.003_bib0022","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ejphar.2014.11.005","article-title":"Hypoxia\/ischemia a key player in early post stroke seizures: modulation by opioidergic and nitrergic systems","volume":"746","author":"Gooshe","year":"2015","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.seizure.2022.07.003_bib0023","doi-asserted-by":"crossref","first-page":"4944","DOI":"10.1073\/pnas.040577097","article-title":"Potent blockade of sodium channels and protection of brain tissue from ischemia by BIII 890 CL","volume":"97","author":"Carter","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.seizure.2022.07.003_bib0024","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s40263-017-0441-0","article-title":"Sodium channel blockers in the treatment of epilepsy","volume":"31","author":"Brodie","year":"2017","journal-title":"CNS Drugs"},{"key":"10.1016\/j.seizure.2022.07.003_bib0025","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s11596-019-2117-0","article-title":"Voltage-gated sodium channels and blockers: an overview and where will they go?","volume":"39","author":"Li","year":"2019","journal-title":"Curr Med Sci"},{"key":"10.1016\/j.seizure.2022.07.003_bib0026","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S1474-4422(10)70059-4","article-title":"Voltage-gated sodium channels as therapeutic targets in epilepsy and other neurological disorders","volume":"9","author":"Mantegazza","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.seizure.2022.07.003_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2019.106574","article-title":"Effectiveness of eslicarbazepine acetate in dependency of baseline anticonvulsant therapy: results from a German prospective multicenter clinical practice study","volume":"101","author":"Weissinger","year":"2019","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2022.07.003_bib0028","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.neuropharm.2014.09.008","article-title":"Eslicarbazepine and the enhancement of slow inactivation of voltage-gated sodium channels: a comparison with carbamazepine, oxcarbazepine and lacosamide","volume":"89","author":"Hebeisen","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.seizure.2022.07.003_bib0029","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/epi.13602","article-title":"Activity of the anticonvulsant lacosamide in experimental and human epilepsy via selective effects on slow Na(+) channel inactivation","volume":"58","author":"Holtkamp","year":"2017","journal-title":"Epilepsia"}],"container-title":["Seizure: European Journal of Epilepsy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105913112200156X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105913112200156X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T02:02:08Z","timestamp":1761012128000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S105913112200156X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":29,"alternative-id":["S105913112200156X"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2022.07.003","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of antiseizure medication in post-stroke epilepsy","name":"articletitle","label":"Article Title"},{"value":"Seizure: European Journal of Epilepsy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2022.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 British Epilepsy Association. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}